The association of obesity and cardiometabolic traits with incident HFpEF and HFrEF

N Savji, WC Meijers, TM Bartz, V Bhambhani… - JACC: Heart Failure, 2018 - jacc.org
Objectives: This study evaluated the associations of obesity and cardiometabolic traits with
incident heart failure with preserved versus reduced ejection fraction (HFpEF vs. HFrEF) …

Surgery does not improve survival in patients with isolated severe tricuspid regurgitation

AL Axtell, V Bhambhani, P Moonsamy… - Journal of the American …, 2019 - jacc.org
Background: Patients with isolated tricuspid regurgitation (TR) in the absence of left-sided
valvular dysfunction are often managed nonoperatively. Objectives: The purpose of this …

Association of cardiovascular biomarkers with incident heart failure with preserved and reduced ejection fraction

RA De Boer, M Nayor, CR DeFilippi, D Enserro… - JAMA …, 2018 - jamanetwork.com
Importance Nearly half of all patients with heart failure have preserved ejection fraction
(HFpEF) as opposed to reduced ejection fraction (HFrEF), yet associations of biomarkers …

Predictors and outcomes of heart failure with mid‐range ejection fraction

V Bhambhani, JR Kizer, JAC Lima… - European journal of …, 2018 - Wiley Online Library
Aims While heart failure with preserved (HFpEF) and reduced ejection fraction (HFrEF) are
well described, determinants and outcomes of heart failure with mid‐range ejection fraction …

Adipsin preserves beta cells in diabetic mice and associates with protection from type 2 diabetes in humans

N Gómez-Banoy, JS Guseh, GE Li, A Rubio-Navarro… - Nature medicine, 2019 - nature.com
Type 2 diabetes is characterized by insulin resistance and a gradual loss of pancreatic beta
cell mass and function,. Currently, there are no therapies proven to prevent beta cell loss …

Sex differences in circulating biomarkers of cardiovascular disease

ES Lau, SM Paniagua, JS Guseh, V Bhambhani… - Journal of the American …, 2019 - jacc.org
Background: Differences in proteomic profiles between men and women may provide
insights into the biological pathways that contribute to known sex differences in …

Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA …

G Mingrone, ACG Van Baar, J Devière, D Hopkins… - Gut, 2022 - gut.bmj.com
Objective Hydrothermal duodenal mucosal resurfacing (DMR) is a safe, outpatient
endoscopic procedure. REVITA-2, a double-blind, superiority randomised controlled trial …

Longitudinal change in galectin-3 and incident cardiovascular outcomes

A Ghorbani, V Bhambhani, RH Christenson… - Journal of the American …, 2018 - jacc.org
Abstract Background: Galectin-3 (Gal-3) has been associated with heart failure (HF) and
poor cardiovascular outcomes. However, the effect of longitudinal changes in Gal-3 on …

Obesity is associated with pulmonary hypertension and modifies outcomes

RC Frank, J Min, M Abdelghany… - Journal of the …, 2020 - Am Heart Assoc
Background Experimental studies support a link between obesity and pulmonary
hypertension (PH), yet clinical studies have been limited. This study sought to determine the …

[HTML][HTML] Durable metabolic improvements 2 years after duodenal mucosal resurfacing (DMR) in patients with type 2 diabetes (REVITA-1 Study)

ACG van Baar, J Devière, D Hopkins, L Crenier… - Diabetes research and …, 2022 - Elsevier
Aims Duodenal mucosal resurfacing (DMR) is an endoscopic procedure developed to
improve metabolic parameters and restore insulin sensitivity in patients with diabetes. Here …